Epitomee closes USD 8m in equity fund round led by XT Hi-Tech.
BANKING AND CREDIT NEWS-April 16, 2019-Epitomee closes USD 8m in equity fund round led by XT Hi-Tech
(C)2019 M2 COMMUNICATIONS http://www.m2.com
Epitomee Medical has announced the closing of a USD 8 million equity financing led by Israel-based XT Hi-Tech with participation from investors GCB and Dr. Shimon Eckhouse, the company said.
The funding will enable the company to run its next phase clinical trial equivalent to a Phase 2B drug clinical trial.
Epitomee is a bio-medical company developing treatments for the overweight and obese population, including treatment of glycemic control, weight reduction, and hypertension based on its unique swallowable-device gastric retention platform.
((Comments on this story may be sent to email@example.com))